Skip to main content
TipRanks
Go Ultimate75% OFF

Jason Shackelford Insider Profile

4 Followers

Jason Shackelford, former Prin Fin. & Acct. Officer at Oncternal Therapeutics, holds 19.55K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Jason Shackelford Sold 9,279 shares of Oncternal Therapeutics on Jun 22, 2018 for an estimated value of $176.30K.

Jason Shackelford's Trading History

ONCT
Oncternal Therapeutics
Jun 22, 2018―Informative Sell176.30K$10.28K
ONCT
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 22, 2018Informative Sell$176.30K9,279$19.00+94.30%
Jan 09, 2018Informative Sell$35.02K3,090$11.33+90.80%
Jan 03, 2018Uninformative Sell$34.37K2,704$12.71―
Feb 20, 2015Uninformative Buy$0.00300,000$0.00―
Aug 07, 2014Informative Buy$9.10K10,000$0.910.00%

You May Also Like

Jason Shackelford insider profile FAQ

What is the percentage of profitable transactions made by Jason Shackelford?
The percentage of profitable transactions made by Jason Shackelford is 67%.
What is the average return per transaction made by Jason Shackelford?
The average return per transaction made by Jason Shackelford is 61.70%.
What stocks does Jason Shackelford hold?
Jason Shackelford holds: ONCT stocks.
What was Jason Shackelford’s latest transaction?
Jason Shackelford’s latest transaction was an Informative Sell of $176.30K.
What was Jason Shackelford's most profitable transaction?
Jason Shackelford’s most profitable transaction was an Informative Sell of ONCT stock on June 22, 2018. The return on the trade was 94.30%.
What is Jason Shackelford's role in Oncternal Therapeutics?
Jason Shackelford's role in Oncternal Therapeutics is Prin Fin. & Acct. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.